182 related articles for article (PubMed ID: 29931581)
21. FFAR1/GPR40 Contributes to the Regulation of Striatal Monoamine Releases and Facilitation of Cocaine-Induced Locomotor Activity in Mice.
Sadamura Y; Thapa S; Mizunuma R; Kambe Y; Hirasawa A; Nakamoto K; Tokuyama S; Yoshimoto K; Arita K; Miyata A; Oyoshi T; Kurihara T
Front Pharmacol; 2021; 12():699026. PubMed ID: 34489696
[TBL] [Abstract][Full Text] [Related]
22. Cloning, identification and functional characterization of bovine free fatty acid receptor-1 (FFAR1/GPR40) in neutrophils.
Manosalva C; Mena J; Velasquez Z; Colenso CK; Brauchi S; Burgos RA; Hidalgo MA
PLoS One; 2015; 10(3):e0119715. PubMed ID: 25790461
[TBL] [Abstract][Full Text] [Related]
23. Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.
Kohara K; Obata A; Kimura T; Shimoda M; Moriuchi S; Okauchi S; Hirukawa H; Mune T; Kaku K; Kaneto H
Endocr J; 2019 Jan; 66(1):43-50. PubMed ID: 30333365
[TBL] [Abstract][Full Text] [Related]
24. Effects of social defeat stress on dopamine D2 receptor isoforms and proteins involved in intracellular trafficking.
Prabhu VV; Nguyen TB; Cui Y; Oh YE; Lee KH; Bagalkot TR; Chung YC
Behav Brain Funct; 2018 Oct; 14(1):16. PubMed ID: 30296947
[TBL] [Abstract][Full Text] [Related]
25. [A New Pain Regulatory System via the Brain Long Chain Fatty Acid Receptor GPR40/FFA1 Signal].
Nakamoto K
Yakugaku Zasshi; 2017; 137(2):199-204. PubMed ID: 28154332
[TBL] [Abstract][Full Text] [Related]
26. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
[TBL] [Abstract][Full Text] [Related]
27. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease.
Lan H; Hoos LM; Liu L; Tetzloff G; Hu W; Abbondanzo SJ; Vassileva G; Gustafson EL; Hedrick JA; Davis HR
Diabetes; 2008 Nov; 57(11):2999-3006. PubMed ID: 18678612
[TBL] [Abstract][Full Text] [Related]
28. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
29. Dual effects of the non-esterified fatty acid receptor 'GPR40' for human health.
Yamashima T
Prog Lipid Res; 2015 Apr; 58():40-50. PubMed ID: 25615413
[TBL] [Abstract][Full Text] [Related]
30. Long-Chain Free Fatty Acid Receptor GPR120 Mediates Oil-Induced GIP Secretion Through CCK in Male Mice.
Sankoda A; Harada N; Iwasaki K; Yamane S; Murata Y; Shibue K; Thewjitcharoen Y; Suzuki K; Harada T; Kanemaru Y; Shimazu-Kuwahara S; Hirasawa A; Inagaki N
Endocrinology; 2017 May; 158(5):1172-1180. PubMed ID: 28324023
[TBL] [Abstract][Full Text] [Related]
31. Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells.
Kita T; Kadochi Y; Takahashi K; Fukushima K; Yamasaki E; Uemoto T; Hirane M; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2016 Mar; 342(2):193-9. PubMed ID: 26968637
[TBL] [Abstract][Full Text] [Related]
32. Regulation of prohormone convertase 2 protein expression via GPR40/FFA1 in the hypothalamus.
Nakamoto K; Aizawa F; Nishinaka T; Tokuyama S
Eur J Pharmacol; 2015 Sep; 762():459-63. PubMed ID: 26071852
[TBL] [Abstract][Full Text] [Related]
33. [The possibility of a novel pain control system through brain long chain fatty acid receptor GPR40/FFAR1].
Nakamoto K; Tokuyama S
Nihon Yakurigaku Zasshi; 2015 Dec; 146(6):302-8. PubMed ID: 26657120
[No Abstract] [Full Text] [Related]
34. [Involvement of free fatty acid receptor GPR40/FFAR1 in the regulation of spinal nociceptive transmission].
Kurihara T; Miyata A
Nihon Yakurigaku Zasshi; 2015 Dec; 146(6):309-14. PubMed ID: 26657121
[No Abstract] [Full Text] [Related]
35. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway.
Mao XF; Wu HY; Tang XQ; Ali U; Liu H; Wang YX
J Neuroinflammation; 2019 Apr; 16(1):84. PubMed ID: 30981281
[TBL] [Abstract][Full Text] [Related]
36. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
37. [A long chain fatty acid receptor GPR40 as a novel pain control system].
Nakamoto K; Tokuyama S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):233-7. PubMed ID: 23012892
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Development of GPR40 Modulators (FFA1/FFAR1): An Emerging Target for Type 2 Diabetes.
Sharma N; Bhagat S; Chundawat TS
Mini Rev Med Chem; 2017; 17(11):947-958. PubMed ID: 28117025
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the long-chain fatty acid receptor GPR40 in depression-related behavior.
Nishinaka T; Yamashita T; Nakamoto K; Kasuya F; Tokuyama S
J Pharmacol Sci; 2014; 125(1):112-5. PubMed ID: 24758921
[TBL] [Abstract][Full Text] [Related]
40. Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships.
Paul A; Nahar S; Nahata P; Sarkar A; Maji A; Samanta A; Karmakar S; Maity TK
Eur J Med Chem; 2024 Jan; 264():115990. PubMed ID: 38039791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
